Archive
ArchivePosts
Mar
19 | 2022
SOURCE, also known as SPIROMICS Study of Early COPD Progression, is a study to help us discover why some smokers get lung disease at a young age, while others don’t. Most studies of COPD have enrolled older individuals, while...
Mar
19 | 2022
The Lung Health Cohort (LHC) study is the first federally funded, community-based cohort study of millennials in the nation. This study aims to discover what biomarkers as well as genetic and environmental factors lead to the development of lung...
Feb
28 | 2021
Chronic Obstructive Pulmonary Disease (COPD) affects at least 15 million Americans and is one of the leading cause of death in the U.S. COPD exacerbations lead to about 700,000 hospitalizations in the U.S. each year. Clinical trials and guidelines...
Feb
27 | 2021
LEEP (Losartan Effects on Emphysema Progression) was a clinical trial for adults over the age of 40 who have mild to severe Chronic Obstructive Pulmonary Disease (COPD). The purpose of this study was to learn how a medicine called...
Feb
26 | 2021
INSIGHT COPD (INtervention Study In overweiGHT patients with COPD) was a clinical trial to find out if a 12 month lifestyle program that promotes modest weight loss and increased physical activity would improve Chronic Obstructive Pulmonary Disease (COPD) symptoms...
Feb
24 | 2021
PELICAn (PEer-Led o2 Info-line for patients and Caregivers) tested whether a patient-centered telephone support increased adherence and improved the health of patients with Chronic Obstructive Pulmonary Disease (COPD) using supplemental oxygen. PELICAn was funded by the Patient-Centered Outcomes Research...
Feb
23 | 2021
SPIROMICS (SubPopulations and InteRmediate Outcomes Measures In COPD Study) collects and analyzes phenotypic, biomarker, genetic, genomic, and clinical data from participants with COPD for the purpose of identifying sub-populations and intermediate outcome measures. SPIROMICS is sponsored by the National...
Feb
22 | 2021
The University of Illinois at Chicago is one of 6 sites nationwide to participate in the CONCERT study (COPD Outcomes-based Network for Clinical Effectiveness Research Translation). Clinical trials in Chronic Obstructive Pulmonary Disease (COPD) usually require evidence of airflow...
Feb
21 | 2021
STATCOPE (SimvaSTATin in the Prevention of COPD Exacerbations) was a clinical trial that investigated whether use of simvastatin, a medicine typically used to lower cholesterol, decreased the number and seriousness of COPD flare-ups. The STATCOPE study has been completed.
Feb
18 | 2021
PRR (Pulmonary Research Registry) is a community of people interested in lung health. Joining the registry lets researchers know you would like to be contacted about participating in research. Dr. Jerry Krishnan is a lung doctor and researcher at...